Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GWR Medical is a medical device company focused on advanced wound care through the application of topical oxygen therapy (TOT). The company develops and manufactures specialized delivery systems, including the O2Boot and O2Sac, which provide 100% oxygen directly to chronic wounds at slightly atmospheric pressure. These products are designed to treat difficult-to-heal conditions such as diabetic foot ulcers, venous stasis ulcers, and pressure sores. By increasing local oxygen tension, the therapy promotes collagen synthesis, angiogenesis, and bacterial suppression. GWR Medical's solutions are intended for use in hospitals, wound care centers, and home health settings. The company's technology is FDA-cleared and offers a portable, cost-effective alternative to traditional hyperbaric oxygen chambers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GWR Medical.